News

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.
The framework the new FDA leaders laid out on Tuesday raised small and big questions about the regulatory process, vaccine ...
Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...
With vaccine approval process set to change, FDA advisers leave wiggle room in annual Covid-19 shot recommendations
A group of experts who advise the US Food and Drug Administration on its vaccine decisions voted unanimously Thursday to make ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk individuals
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
Phoenix doctor weighs in on possible limited access to COVID-19 shots
A Phoenix doctor weighs in on the potential impact of FDA plans to limit COVID booster access to high-risk groups, raising ...
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a public health expert explains the new rules
The FDA’s new framework for COVID-19 vaccines breaks from established procedure for how the government establishes vaccine ...
Vaccine skeptics baselessly blame Covid-19 shots for Biden cancer diagnosis
Almost immediately after former US president Joe Biden's office announced he had been diagnosed with an aggressive prostate ...
Dr. Peter McCullough: Covid Vaccine Myocarditis Is Real, Over 200 Deaths This Year
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...